New insight into the control of peptic ulcer by targeting the histamine H2 receptor

J Cell Biochem. 2018 Feb;119(2):2003-2011. doi: 10.1002/jcb.26361. Epub 2017 Sep 7.

Abstract

Peptic ulcer disease is one of the major challenges in public health globally and new evidence shows that it can be controlled by targeting the histamine H2 receptor (H2 R). Recently, a number of H2 R antagonists have been synthesized and used to block the action of histamine on the parietal cells in the stomach and decrease the acid production. In this study, we modeled the H2 R by homology modeling using the 3-D crystal structure and this model was validated based on free energy and amino acid residues present in the allowed regions of a Ramachandran plot. We used this 3-D model for screening of highly potent drugs using molecular docking. We found cimetidine, cimetex, and famotidine as the most potent drugs based on the binding affinity of drug-protein interactions. We also generated a cellular network for H2 R that could be useful for better understanding of cellular mechanism and drug targets. These findings provide a new insight into the development of suitable, specific, and effective anti-ulcer drugs for a most effective treatment of ulcerous diseases.

Keywords: anti-ulcer drugs; cellular network; docking; histamine H2 receptor; homology modeling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Crystallography, X-Ray
  • Drug Evaluation, Preclinical
  • Histamine H2 Antagonists / chemistry
  • Histamine H2 Antagonists / pharmacology*
  • Humans
  • Hydrogen Bonding
  • Models, Molecular
  • Molecular Docking Simulation
  • Peptic Ulcer / drug therapy*
  • Peptic Ulcer / metabolism
  • Protein Structure, Secondary
  • Receptors, Histamine H2 / chemistry*
  • Receptors, Histamine H2 / metabolism*
  • Structural Homology, Protein
  • Structure-Activity Relationship

Substances

  • Histamine H2 Antagonists
  • Receptors, Histamine H2